34. 神経線維腫症 Neurofibromatosis Clinical trials / Disease details

臨床試験数 : 133 / 薬物数 : 186 - (DrugBank : 67) / 標的遺伝子数 : 79 - 標的パスウェイ数 : 190

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00973739 (ClinicalTrials.gov)	September 2009	3/9/2009	Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors	Phase II Study of Lapatinibin Children and Adults With Neurofibromatosis Type 2(NF2) and NF2-related ...	Neurofibromatosis 2;Vestibular Schwannoma	Drug: Lapatinib	New York University School of Medicine	GlaxoSmithKline	Completed	4 Years	80 Years	All	21	Phase 2	United States
2	NCT00863122 (ClinicalTrials.gov)	June 2009	13/3/2009	Concentration and Activity of Lapatinib in Vestibular Schwannomas	Exploration and Estimation of Intratumoral Concentration and Activity of Lapatinibin Vivo in Vestibu ...	Vestibular Schwannoma;NF2;Neurofibromatosis 2;Acoustic Neuroma;Auditory Tumor	Drug: lapatinib	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	The Children's Tumor Foundation;GlaxoSmithKline;New York University;Ohio State University;House Rese ...	Completed	18 Years	N/A	All	26	Early Phase 1	United States

First Previous1Next Last